```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[S. 2667 Introduced in Senate (IS)]

108th CONGRESS
  2d Session
                                S. 2667

 To amend section 641 of the Medicare Prescription Drug, Improvement, 
   and Modernization Act of 2003 to improve the coverage of certain 
prescription drugs and biologicals under the medicare replacement drug 
                         demonstration project.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 15, 2004

  Mr. Dayton introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To amend section 641 of the Medicare Prescription Drug, Improvement, 
   and Modernization Act of 2003 to improve the coverage of certain 
prescription drugs and biologicals under the medicare replacement drug 
                         demonstration project.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Medicare Replacement Drug 
Demonstration Project Improvement Act of 2004''.

SEC. 2. MEDICARE REPLACEMENT DRUG DEMONSTRATION PROJECT IMPROVEMENT.

    (a) Requirement To Negotiate Reduced Drug Prices.--Section 641(a) 
of the Medicare Prescription Drug, Improvement, and Modernization Act 
of 2003 (42 U.S.C. 1395l note) is amended by inserting after the first 
sentence the following new sentence: ``Notwithstanding any other 
provision of law, the Secretary shall negotiate the lowest possible 
price for the drugs and biologicals for which payment is made under the 
demonstration project.''.
    (b) Elimination of Limitations; Funding.--Section 641(d) of the 
Medicare Prescription Drug, Improvement, and Modernization Act of 2003 
(42 U.S.C. 1395l note) is amended to read as follows:
    ``(d) Funding.--There are appropriated from the Federal 
Supplementary Medical Insurance Trust Fund under section 1841 of the 
Social Security Act (42 U.S.C. 1395t) such sums as are necessary to 
provide coverage for drugs and biologicals for which payment is made 
under the demonstration project for each individual who is eligible to 
participate in such demonstration project.''.
    (c) Effective Date; Extension of Application Deadline.--
            (1) Effective date.--The amendments made by this section 
        shall take effect as if included in the enactment of section 
        641 of the Medicare Prescription Drug, Improvement, and 
        Modernization Act of 2003 (42 U.S.C. 1395l note).
            (2) Extension of application deadline.--The Secretary shall 
        extend any application deadline imposed under the demonstration 
        project under section 641 of the Medicare Prescription Drug, 
        Improvement, and Modernization Act of 2003 (42 U.S.C. 1395l 
        note) until at least the date that is 90 days after the date of 
        enactment of this Act.
                                 <all>
```